NCT01077323 - A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents | Biotech Hunter

Enrollment

363,766

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies)Healthy Subjects (Treated With no Diabetes Therapies)

Interventions

DRUG

exenatide

subcutaneous injection, dosing according to normal clinical practice

DRUG

Other antidiabetic therapies

Includes metformin, thiazolidinediones, insulins, sulfonylureas, non-sulfonylurea secretagogues, sitagliptin, and alpha-glucosidase inhibitors; In all cases, dosing according to normal clinical practice

OTHER

No diabetes therapy

Subjects not diagnosed with diabetes

Trial Locations (1)

Unknown

Research Site, Waltham